Global Market Size, Forecast, and Trend Highlights Over 2025-2037
EMG Biosensors Market size was valued at USD 683.13 million in 2024 and is expected to reach USD 2.17 billion by 2037, expanding at around 9.3% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of EMG biosensors is assessed at USD 737.13 million.
The reason behind the growth is impelled by increasing cases of musculoskeletal disorders. Musculoskeletal disorders are the main cause of disability, brought on by biomechanical stress, and bodily reaction, overexertion, or repetitive motion. According to the World Health Organization (WHO), musculoskeletal disorders affect about 1.71 billion individuals across the globe.
The growing technological advancements in EMG biosensors are believed to fuel the market growth. For instance, there are now more opportunities for human–machine interfaces (HMI) employing EMG sensors as they can be used in a variety of industries, including virtual reality interfaces, prosthetics, and rehabilitation to give constant signal data, making it possible to track muscle activation in real-time and to predict and classify user movements.
EMG Biosensors Sector: Growth Drivers and Challenges
Growth Drivers
- Growing Geriatric Population Across the Globe - Elderly people are more prone to neuromuscular diseases such as sarcopenia, and the rising number of elderly populations around the globe is estimated to drive market growth. Besides this, elderly people often need physical therapy in which EMG biosensors help in providing real-time feedback and monitoring the progress. According to estimates, the number of individuals in the world who are 60 or older will rise to over 2 billion by 2050.
- Surging Popularity of Minimally Invasive Surgery - The EMG treatment is non-invasive, and its non-invasive nature and practicality are thought to be the key drivers of its widespread implementation. EMG data are collected primarily via the non-invasive technique of skin surface sampling.
- Rising Demand for Wearable Devices - Wearable technology offers an alternative to clinical diagnostics with minimal invasiveness and can be used to track mental health, offer early diagnosis, and perform guided training.
- Increasing Prevalence of Neurological Diseases - Medical professionals frequently employ EMG instruments for the early diagnosis of neurological disorders and are being investigated more and more as assessment tools for impairment in neurological diseases. Moreover, Parkinson's disease one of the most significant in terms of the future global burden of diseases can be identified by EMG, and can also be used to track the effectiveness of treatment. For instance, neurological illnesses make up over 7% of the global incidence of illness.
Challenges
- Exorbitant Cost of EMG Biosensors - EMG biosensors include sensitive electrodes, amplifiers, and other advanced technology that necessitate substantial research and development, which raises the overall production costs. Besides this, the cost and difficulty of acquiring invasive electromyography and surface electromyography (sEMG) are high since they consume a lot of power.
- Inaccurate Data Can Lead to Incorrect Diagnosis and Misinterpretation
- Lack of Standardization and Regulation May Restrict Entry for New EMG Biosensor Technologies
- Privacy and Data Security Concerns
EMG Biosensors Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
9.3% |
|
Base Year Market Size (2024) |
USD 683.13 million |
|
Forecast Year Market Size (2037) |
USD 2.17 billion |
|
Regional Scope |
|
EMG Biosensors Segmentation
End-User (Hospitals and Clinics, Ambulatory Health Clinics, Academic and Research Centers)
The hospitals and clinics segment in the EMG biosensors market is estimated to gain a robust revenue share of 45% in the coming years. The number of patients in the hospital has increased therefore the demand for frequent health monitoring is also rising. This as a result has led to the adoption of EMG biosensors in hospitals and clinics since nurses and other medical staff at hospitals monitor patients' health with wearable biosensors to reduce readmissions, and doctors frequently utilize them in various applications including identifying neurological and neuromuscular diseases, pollution detection, drug development, and others.
Type (Surface Biosensors, and Intramuscular Biosensors)
EMG biosensors market from the surface biosensors segment is set to garner a notable share shortly impelled by the rising need for surface biosensors to assess the level of musculoskeletal disorder. To fulfill the increased demand for precise and quick diagnostics of musculoskeletal illnesses, it is anticipated that the market for surface biosensors will increase. The skin's analog EMG signal is captured by the surface EMG measurement module, which is a non-invasive technique for determining neuromuscular potentials since the EMG signals provide more information about the muscle's activity including joint movement, and posture. Surface electromyography (EMG) is the most used technique for identifying muscle tiredness, and the largest part of a muscle can be covered with sMMG sensors, which can measure physical changes in the muscles.
Our in-depth analysis of the global market includes the following segments:
|
Type |
|
|
Technology |
|
|
End-User |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportEMG Biosensors Industry - Regional Synopsis
North American Market Forecast
EMG biosensors market in North America industry is expected to hold largest revenue share of 40% by 2037, impelled by the rising spending in healthcare. The increasing investment in healthcare has improved the access to healthcare for the people in the region. This has increased the demand for EMG biosensors since more people in the area are becoming aware of health monitoring and the benefits of early diagnosis of neuromuscular diseases.
For instance, the amount spent on health care in the United States increased by more than 4% in 2022 to around USD 4 trillion.
European Market Statistics
The Europe EMG biosensors market is estimated to be the second largest, during the forecast timeframe led by the presence of major key players in the region. This has increased the market accessibility of EMG biosensors, which makes them easily available in healthcare facilities and other platforms. Additionally, the presence of these companies enables significant investment in research and development, which may enhance the demand for more advanced biosensor technology.
Companies Dominating the EMG Biosensors Landscape
- Interaxon Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- OpenBCI Inc.
- Multi Biosensors Inc.
- Innopsys Inc.
- Biometrics Ltd.
- Butler Technologies, Inc.
- mDurance Solutions SL.
- iMotions A/S
- Delsys Incorporated
- Pinnacle Technology
In the News
- Interaxon Inc. introduced New VR SDK & VR Compatible EEG Band to provide strategic partnership opportunities for advancements in brain health. Further, to operate their four-channel EEG system with PPG, ECG, EMG, and EOG biosensing capabilities comfortably under all popular VR HMDs, the company has developed a new Muse S-VR form factor.
- iMotions A/S partnered with Smart Eye to establish the first global center for the study and analysis of human behavior, and to produce holistic human insights. Further, the acquisition will hasten the development of new products for the company and will increase multi-modal data and synchronized analytics.
Author Credits: Radhika Pawar
- Report ID: 3948
- Published Date: Jan 03, 2025
- Report Format: PDF, PPT
